July 28 – August 1, 2024 | McCormick Place, Chicago, IL
Booth #1872
We are thrilled to announce our participation in ADLM 2024 (formerly AACC Annual Scientific Meeting & Clinical Lab Expo), taking place from July 28 to August 1 in Chicago, Illinois. The Association for Diagnostics & Laboratory Medicine (ADLM) is a premier event that brings together industry leaders, researchers, and professionals to explore the latest advancements in diagnostics and laboratory medicine.
Visit our booth #1872 to explore GenScript's latest innovations in antibody generation, protein engineering, and molecular diagnostics. Engage with our team of experts, attend insightful presentations, and discover how our cutting-edge solutions can advance your research and clinical applications. We look forward to connecting with you at this influential event!
GenScript’s Lecture Session
Date/Time: Tuesday, July 30, 12:30 -12:50 p.m. CDT
Lecture Title: Overcoming in vitro diagnostic (IVD) development barriers with GenScript's cutting-edge solutions.
Location: Exhibit Hall Theater #2
Session Overview: Overcoming barriers in the development of in vitro diagnostic (IVD) tests demands cutting-edge solutions and GenScript stands at the forefront to provide advanced technologies for protein expression, antibody development, and nucleic acid methodologies. Join our presentation as we showcase GenScript’s advanced products and services to support every stage of assay development and share a case study in the development of COVID-19 diagnostic tests.
Expected Outcomes:
1. Learn about products and services to accelerate key project timelines.
2. Learn about methodologies available for optimizing the results.
3. Case study example of GenScript IVD commercialization.
Amanda Grimm,
Sr. Segment Marketing Manager
Amanda joined GenScript in 2021 and is the senior segment marketing manager for GenScript's antibody drug discovery and IVD portfolios. Her previous work experience includes immunopathology research of animal diseases, immunoassay development for research and commercialized use, immunoassay manufacturing and licensure, and product management of automation technology and diagnostics. In her current role, Amanda oversees portfolio education, marketing campaign management, and provides sales and distribution support. Amanda has two Bachelor of Science degrees, in Microbiology and Biochemistry, and a Professional Science Masters (PSM) from Washington State University.
Most Popular Products
CRISPR Gene Editing
Antibodies
Protein Electrophoresis and Blotting
Molecular Biology
Stable Cell Lines
Cell Therapy
Diagnostics
Resources
Amanda Grimm,
